| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 07/01/1999 | DE19757984A1 Regulatorische DNA-Sequenzen aus der 5'-Region vom Gen der humanen katalytischen Telomerase-Untereinheit udn deren diagnostische und therapeutische Verwendung Regulatory DNA sequences from the 5 'region of the gene of human telomerase catalytic subunit UDN their diagnostic and therapeutic use |
| 07/01/1999 | CA2316414A1 Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells |
| 07/01/1999 | CA2314614A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |
| 07/01/1999 | CA2314437A1 Mood disorder gene |
| 07/01/1999 | CA2314357A1 Transgenic animal model for degenerative diseases of cartilage |
| 07/01/1999 | CA2311999A1 Genetic inhibition by double-stranded rna |
| 07/01/1999 | CA2311416A1 Prostate cancer gene |
| 06/30/1999 | CN1221450A Spruce bunworm antifreeze proteins, genes and methods of using the same |
| 06/29/1999 | US5917124 Transgenic mouse model of prostate cancer |
| 06/29/1999 | US5917122 Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic mice |
| 06/24/1999 | WO1999031230A2 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | WO1999030743A1 Methods for evaluating a compound for its effect on skin |
| 06/24/1999 | WO1999016888A3 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 06/24/1999 | DE19754938A1 TGC-Verfahren zur Induktion einer zielgerichteten, somatischen Transgenität TGC method for inducing a targeted somatic transgenic |
| 06/24/1999 | CA2315268A1 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/23/1999 | EP0923644A1 G-coupled receptor showing selective affinity for atp |
| 06/23/1999 | EP0923607A1 Method for producing polyclonal and monoclonal antibodies |
| 06/23/1999 | EP0923308A1 Purification of biologically active peptides from milk |
| 06/22/1999 | US5914317 A dna which hybridizes under high stringency conditions to a preferential dna sequence encodes b1k proteins which contains atleast thirty amino acid residues in length; useful for treating dermis disorder such as epidermal bulosis |
| 06/22/1999 | US5914265 Keratin K1 expression vectors and methods of use |
| 06/22/1999 | US5914234 Methods of detecting growth differentiation factor-11 |
| 06/17/1999 | WO1999029896A1 Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof |
| 06/17/1999 | WO1999029884A2 Tgc method for inducting targeted somatic transgenesis |
| 06/17/1999 | WO1999029860A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 06/17/1999 | WO1999029853A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 06/17/1999 | WO1999029846A1 Transgenic mice expressing the h/k-ras 4b chimeric gene |
| 06/17/1999 | DE19754774A1 Transgenes nicht-menschliches Säugetier mit einer onkogenen Mutante des Raf-1-Gens A transgenic non-human mammal with an oncogenic mutant of the Raf-1 gene |
| 06/17/1999 | CA2315216A1 Tgc method for inducting targeted somatic transgenesis |
| 06/17/1999 | CA2312697A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 06/17/1999 | CA2255286A1 Galanin transgenic mice |
| 06/16/1999 | EP0922762A1 Drug binding protein |
| 06/16/1999 | EP0922760A2 Transgenic animal not expressing endogenous osteoclastogenesis inhibitory factor (OCIF) |
| 06/16/1999 | EP0921822A1 Animal model for transplantation |
| 06/15/1999 | US5912411 Mice transgenic for a tetracycline-inducible transcriptional activator |
| 06/15/1999 | US5912410 Transgenic non-human mice displaying the amyloid-forming pathology of alzheimer's disease |
| 06/15/1999 | US5912176 Antibodies against a host cell antigen complex for pre and post exposure protection from infection by HIV |
| 06/10/1999 | WO1999028748A2 Hla-e binding |
| 06/10/1999 | WO1999028508A1 Method of generating conditionally expressed mutant cells using expressible antisense sequences |
| 06/10/1999 | WO1999028463A2 Methods for the degradation and detoxification of organic material using urine produced by transgenic animals |
| 06/10/1999 | WO1999028453A2 Transgenic non-human mammals with an oncogenic mutant of raf gene 1 |
| 06/10/1999 | WO1999028449A2 Yac vectors |
| 06/10/1999 | WO1999027948A2 Use of soluble recombinant human cd40l protein for inhibiting in vivo immune response |
| 06/10/1999 | WO1999007737A3 Lsr receptor, cloning and uses |
| 06/10/1999 | WO1999006545A8 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
| 06/10/1999 | CA2311282A1 Yac vectors |
| 06/09/1999 | EP0921189A1 Transgenic animal allergy models and methods for their use |
| 06/09/1999 | EP0920498A1 HAMSTER EF-1$g(a) TRANSCRIPTIONAL REGULATORY DNA |
| 06/09/1999 | EP0920495A1 Transgenic animal model for alzheimer disease |
| 06/09/1999 | EP0920254A1 Programmed cell death and ich-3 |
| 06/09/1999 | CN1219198A Cultured inner cell mass cells derived from ungulate embryos |
| 06/09/1999 | CA2218199A1 Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof |
| 06/03/1999 | WO1999027113A1 Mouse telomerase reverse transcriptase |
| 06/03/1999 | WO1999027105A2 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 06/03/1999 | WO1999027104A1 Histamine and serotonin binding molecules |
| 06/03/1999 | WO1999027103A1 Mammalian cytokine-like polypeptide-10 |
| 06/03/1999 | WO1999027076A1 Pluripotent embryonic stem cells and methods of obtaining them |
| 06/03/1999 | CA2312000A1 Mammalian cytokine-like polypeptide-10 |
| 06/03/1999 | CA2311396A1 Pluripotent embryonic stem cells and methods of obtaining them |
| 06/03/1999 | CA2309809A1 Histamine and serotonin binding molecules |
| 06/03/1999 | CA2307846A1 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 06/02/1999 | EP0919122A1 Hepatitis c model animals |
| 06/02/1999 | EP0919121A1 In vivo electroporation method for early animal embryo |
| 06/02/1999 | EP0918860A2 Tumor necrosis factor-related polypeptide |
| 06/02/1999 | EP0918855A1 Polycystic kidney disease gene |
| 06/02/1999 | EP0918532A1 A novel method of detecting and treating cancer |
| 06/02/1999 | EP0918455A1 Galanin |
| 06/02/1999 | EP0837931A4 Method for expression and isolation of biologically active molecules in urine |
| 06/02/1999 | CA2254949A1 Transgenic animal |
| 06/02/1999 | CA2223075A1 Drug binding protein |
| 06/01/1999 | US5908969 Method of detecting prions in a sample and transgenic animal used for same |
| 05/28/1999 | CA2223225A1 Method for inhibiting in vivo immune response |
| 05/27/1999 | WO1999025863A1 Transfection and transfer of male germ cells for generation of transgenic species |
| 05/27/1999 | WO1999025857A2 Transgenic models of inflammatory disease |
| 05/27/1999 | WO1999025851A1 VARIANT loxP SEQUENCES AND APPLICATION OF THE SAME |
| 05/27/1999 | WO1999025843A2 Human checkpoint kinase, hcds1, compositions and methods |
| 05/27/1999 | WO1999025829A2 Cdk2 protein and cdk2 protein complexes |
| 05/27/1999 | WO1999025817A2 Tc1-based transposon vectors |
| 05/27/1999 | WO1999025815A2 Nucleic acids involved in the responder phenotype and applications thereof |
| 05/27/1999 | WO1999025810A1 Transgenic animal models for human bladder cancer |
| 05/27/1999 | WO1999014330A8 DcR3 POLYPEPTIDE, A TNFR HOMOLOG |
| 05/27/1999 | WO1999013092A9 Enhancement of mucosal antibody responses by interleukin-6 |
| 05/27/1999 | CA2309904A1 Transfection and transfer of male germ cells for generation of transgenic species |
| 05/27/1999 | CA2309807A1 Transgenic models of inflammatory disease |
| 05/27/1999 | CA2309390A1 Cdk2 protein and cdk2 protein complexes |
| 05/27/1999 | CA2309000A1 Tc1-based transposon vectors |
| 05/27/1999 | CA2306492A1 Human checkpoint kinase, hcds1, compositions and methods |
| 05/26/1999 | EP0917581A1 Fusion polypeptides com0prising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 05/26/1999 | EP0917579A1 Vertebrate telomerase genes and proteins and uses thereof |
| 05/26/1999 | EP0917538A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications |
| 05/26/1999 | EP0917423A1 Aquaculture of marine worms |
| 05/26/1999 | CN1217750A Monoclonal antibody to CEA, Conjugates comprising said antibody, and their therapeutic use in ADEPT system |
| 05/26/1999 | CN1217746A Pluripotent rabbit embryonic stem (ES) cell lines and their use in generation of chimeric rabbits |
| 05/26/1999 | CN1217384A Method for breeding quick-growth transgenosis animals |
| 05/25/1999 | US5907080 Method for development of transgenic dwarf goats |
| 05/25/1999 | US5907078 In vivo model systems that adequately reproduce the spectrum of benign, latent, aggressive and metastatic forms of the human disease. |
| 05/25/1999 | US5906821 Viral nucleotide sequences |
| 05/25/1999 | US5906175 Controlled asexual propagation of certain marine invertebrates by means of segmental transplantation |
| 05/20/1999 | WO1999024572A1 Genes with restricted expression in mesencephalic dopaminergic neurons |
| 05/20/1999 | WO1999024571A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
| 05/20/1999 | WO1999024570A1 Ciita-interacting proteins and methods of use therefor |